Trial intelligence / Profile preview

Computerized Cognitive Remediation Therapy for Chronic Schizophrenia

NCT03772951Phase 4Completed

Sponsor
Shanghai Mental Health Center
Start
Jan 2019
Primary completion
Mar 2021
Countries
1
01

Overview

Phase 4, randomised trial in schizophrenia (2 arms), sponsored by Shanghai Mental Health Center. Primary endpoints: Positive and Negative Syndrome Scale at 12 weeks and Brain Derived Neurotrophic Factor at 12 weeks. Started Jan 2019; status: completed.

02

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT03772951.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03772951.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call